Company news

Merck KGaA news in 2026

Merck KGaA's news releases, calls and decks from 2026, newest first.

View company

Darmstadt, Germany, to Divest CDMO Business to Lonza

November 3, 2026

Merck KGaA: MilliporeSigma Opens €300 Million Asia-Pacific Bioprocessing Center in Daejeon

October 29, 2026

Darmstadt, Germany to Acquire Silence Therapeutics, Strengthening Rare Disease Pipeline with Innovative siRNA Asset

October 19, 2026

New EMD Electronics Survey Highlights Capacity Challenges in the Semiconductor Industry

October 15, 2026

IVD Raw Material Market Report Now Available — Forecasts Market Growth from $21.5B (2026) to $31.1B by 2031, Profiling Merck KGaA, Thermo Fisher, Bio-Techne, Fapon Biotech, and 21 Other Key Players

September 8, 2026

The Hashgraph Group and Merck with support from PwC Germany develop solution for cocoa traceability and digital product passports

September 8, 2026

Münchener Rückversicherungs-Gesellschaft AG: Mari-Lizette Malherbe, buy

August 10, 2026

Merck Opens BioReliance® Testing Facility in Darmstadt, Germany to Support Drug Product Release in Europe

July 16, 2026

Merck KGaA: MilliporeSigma Announces BioReliance® Testing Facility Opening in Darmstadt, Germany

July 16, 2026

Merck KGaA: European Commission Approves Erbitux® (cetuximab) in Combination with Encorafenib and FOLFOX for First-Line Treatment of Metastatic Colorectal Cancer with BRAF V600E Mutation

July 14, 2026

Merck KGaA: Darmstadt, Germany, Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients with Active Skin Manifestations

July 8, 2026

Merck KGaA: Merck Agrees to Acquire Bio-Techne Corporation

June 25, 2026

Merck KGaA: Darmstadt, Germany, Announces Healthcare Leadership Changes for Global Commercial Strategy and North America

June 24, 2026

Merck KGaA, Darmstadt, Germany, Collaborates with Versant Ventures to Launch Saturnus Bio to Advance Treatments for Rare Genetic Cardiomyopathies

June 23, 2026

Merck KGaA: MilliporeSigma Appoints New Heads of Discovery Solutions and Strategy & BD

June 8, 2026

Merck KGaA, Darmstadt, Germany Selects Veeva Vault CRM Worldwide

May 27, 2026

Merck KGaA, Darmstadt, Germany, Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer

May 21, 2026

Q1 26 Press Release

May 13, 2026

Merck KGaA: Darmstadt, Germany, Delivers Solid Start to the Year and Upgrades Full-Year Guidance

May 13, 2026

MilliporeSigma Becomes Sole Testing Provider for Genetix Biotherapeutics’ FDA-Approved Gene Therapies

May 7, 2026

Merck KGaA: Darmstadt, Germany, Opens €20 million Metrology and Inspection Site in France for Global Chip Industry

May 5, 2026

Merck KGaA, Darmstadt, Germany, Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations

April 30, 2026

Remepy Announces Collaboration with Merck KGaA, Darmstadt Germany to Advance Hybrid Drugs Across Therapeutic Areas

April 28, 2026

MilliporeSigma Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography

April 21, 2026

Pharmaceutical Testing Services Market Set to Witness Significant Growth by 2026-2033 |Merck KGaA, Boston Analytical

April 16, 2026

Sodium Benzoate Market Surges to Reach $2.85 Billion by 2036 at 5.4% CAGR with Merck KGaA, DuPont, Lanxess AG, Avantor

April 7, 2026

MilliporeSigma Completes Acquisition of JSR Life Sciences’ Chromatography Business, Expanding Protein A Capabilities and Downstream Portfolio

April 1, 2026

Merck KGaA, Darmstadt, Germany: Guidance for 2025 Delivered, Growth Foundation in Place

March 5, 2026

EMD Serono Advances Patient Access to IVF Medicines in the U.S., Aligned with National Health Priorities

February 6, 2026

Benjamin Hein Appointed as Member of the Executive Board of Merck KGaA, Darmstadt, Germany, and CEO of Electronics

January 29, 2026

Merck and ChemLex Sign Memorandum of Understanding to Advance Automated Chemistry and Technological Innovation

January 20, 2026

FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor

January 12, 2026

Calls in 2026

Decks in 2026